Medscape | Top News From ACR 2013: Slideshow Medscape Rituximab (Rituxan, Genentech) is a potential treatment option in immunoglobulin G4-related disease (IgG4), say researchers reporting first evidence. Lead investigator John Stone, MD, from Massachusetts General Hospital in Boston, has worked on much of ... |
